Iron metabolism in obesity: How interaction between homoeostatic mechanisms can interfere with their original purpose. Part I: Underlying homoeostatic mechanisms of energy storage and iron metabolisms and their interaction

Journal of Trace Elements in Medicine and Biology

Volumn 30, Issue , 2015, Pages 195-201

  Becker, Christiane ^a   Orozco, Mónica ^b,c   Solomons, Noel W ^b   Schümann, Klaus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Center for Studies of Sensory Impairment Aging and Metabolism Guatemala   (Guatemala)

^c Universidad de Valle   (Guatemala)

Author keywords

Epidemiology; History; Inflammation; Iron metabolism; Obesity

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE; HEPCIDIN; IRON; LAMIN; LEPTIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN P53; REACTIVE OXYGEN METABOLITE; ZINC;

ADIPOSE TISSUE; ANGIOGENESIS; APOPTOSIS; BIOLOGICAL MODEL; CELL LINE; CELL NUCLEUS; DEFICIENCY; ENERGY METABOLISM; ENERGY STORAGE; ENZYME ACTIVATION; HOMEOSTASIS; HUMAN; INFLAMMATION; IRON ABSORPTION; IRON METABOLISM; LIPOTOXICITY; METABOLISM; MITOCHONDRION; NEURAL STEM CELL; NONHUMAN; OBESITY; OXIDATIVE STRESS; PHOSPHORYLATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; WEIGHT REDUCTION;

APOPTOSIS; APOPTOSIS INDUCING FACTOR; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL LINE; CELL NUCLEUS; DEFICIENCY; ENZYME ACTIVATION; HUMANS; LAMINS; METABOLISM; MITOCHONDRIA; MODELS, BIOLOGICAL; NEURAL STEM CELLS; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; ZINC;

EID: 84940167152     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2014.10.011     Document Type: Review

References (63)

1. Darwin C. On the origin of species by means of natural selection 1859, John Murray, London.
2. Van Grouw J.M., Volpe S.L. Childhood obesity in America. Curr Opin Endocrinol Diabetes Obes 2013, 20:396-400.
3. Brakenhielm E., Cao R., Gao B., Angelin B., Cannon B., Parini P., et al. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res 2004, 94:1579-1588.
4. Freedman D.S., Khan L.K., Dietz W.H., Srinivasan S.R., Berenson G.S. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics 2008, 108:712-718.
5. Skurk T., Alberti-Huber C., Herder C., Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007, 92:1023-1033.
6. Harman-Boehm I., Bluher M., Redel H., Sion-Vardy N., Ovadia S., Avinoach E., et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007, 92:2240-2247.
7. Gordon S. Macrophage heterogeneity and tissue lipids. J Clin Investig 2007, 117:89-93.
8. Canello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005, 54:2277-2286.
9. Apovian C.M., Bigornia S., Mott M., Meyers M.R., Ullor J., Gagua M., et al. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol 2008, 28:1654-1659.
10. Sengenes C., Miranville A., Lolmede K., Curat C.A., Bouloumie A. The role of endothelial cells in inflamed adipose tissue. J Intern Med 2007, 262:415-421.
11. Curat C.A., Miranville A., Sengenes C., Diehl M., Tonus C., Busse R., et al. From monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004, 53:1285-1292.
12. Nishimura S., Manabe I., Nagasaki M., Seo K., Yamashita H., Hosoya Y., et al. In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J Clin Investig 2008, 118:710-721.
13. Ferri C., Desideri G., Valenti M., Bellini C., Pasin M., Santucci A., et al. Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension 1999, 34:568-573.
14. Spalding K.L., Arner E., Westermark P.O., Barnard S., Buchholz B.A., Bergmann O., et al. Dynamics off at cell turnover in humans. Nature 2008, 453:783-787.
15. Jiao P., Chen Q., Shah S., Du J., Tao B., Tzameli I., et al. Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-kappaB and c-Jun NH2-terminal kinase pathways. Diabetes 2009, 58:104-115.
16. Trayhurn P., Wang B., Wood I.S. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity. Br J Nutr 2008, 100:227-235.
17. Cinti S., Mitchell G., Barbatelli G., Murano I., Ceresi E., Faloia E., et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005, 46:2347-2355.
18. Wang B., Wood I.S., Trayhurn P. Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 2007, 455:479-492.
19. Ye J., Gao Z., Yin J., He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mic. Am J Physiol Endocrinol Metab 2007, 293:E1118-E1128.
20. Cnop M. Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes. Biochem Soc Trans 2008, 36:348-352.
21. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Investig 2006, 116:3015-3025.
22. Vitseva O.I., Tanriverdi K., Tchkonia T.T., Kirkland J.L., Mc Donnell M.E., Apovian C.M., et al. Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) 2008, 16:932-937.
23. Suganami T., Mieda T., Itoh M., Shimoda Y., Kamei Y., Ogawa Y. Attentuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem Biophys Res Commun 2007, 354:45-49.
24. Beard J.L., Dawson H.D. Iron. Handbook of nutritionally essential mineral elements 1997, 275-334. Marcel Dekker, New York. B.L. O'Dell, R.A. Sunde (Eds.).
25. Alderman H., Horton S. The economics of addressing nutritional anemia. Nutritional anemia 2007, 19-35. Sight and Life Press, (Ch III). K. Kraemer, M.D. Zimmermann (Eds.).
26. Nairz M., Schroll A., Sonnweber T., Weiss G. The struggle for iron - a metal at the host-pathogen interface. Cell Microbiol 2010, 12:1691-1702.
27. Crichton R. Iron uptake by plants and fungi. Iron metabolism 2009, 103-139. Wiley & Sons, Chichester. R. Crichton (Ed.).
28. Camaschella C. Iron and hepcidin: a story of recycling and balance. Hematol Am Soc Hematol Educ Program 2013, 1-8. 10.1182/asheducation-20131.1.
29. Hentze M.W., Muckenthaler M.U., Galy B., Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell 2010, 142:24-38.
30. Ghosh M.C., Zhang D.L., Jeong S.Y., Kovtunovych G., Ollivierre-Wilson H., Noguchi A., et al. Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2α. Cell Metab 2013, 17:271-281.
31. Anderson S.A., Nizzi C.P., Chang Y.I., Deck K.M., Schmidt P.J., Galy B., et al. The IRPI-HIF-2α axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption. Cell Metab 2013, 17:282-290.
32. Silvestri L., Pagani A., Nai A., De Domenico I., Kaplan J., Camaschella C. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 2008, 8:502-511.
33. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997, 388:482-488.
34. Vanoaica L., Darshan D., Richman L., Schümann K., Kühn L. Intestinal ferritin H is required for an accurate control of iron aborption. Cell Metabol 2010, 12:273-282.
35. McKie A.T., Barrow D., Latunde-Dada G.O., Rolfs A., Sager G., Mudaly E., et al. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 2001, 291:1755-1759.
36. Vulpe C.D., Kuo Y.M., Murphy T.L., Cowley L., Askwith C., Libina N., et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 1999, 21:195-199.
37. Hoppe J.O., Marcelli H.M.A., Tainter M.L.A. A review on the toxicity of iron compounds. Am J Sci 1955, 230:558-571.
38. Green P., Evitor J.M., Sivota P., Avidor I. Secondary haemochromatosis due to prolonged iron ingestion. Isr J Med Sci 1989, (4):199-201.
39. Bacon B.R. Hemochromatosis: diagnosis and management. Gastroenterology 2001, 120:718-725.
40. Wenzel B.J., Stults H.B., Mayer J. Hypoferreamia in obese adolescents. Lancet 1962, 2:327-328.
41. Amato A., Santoro N., Calabrò P., Grandone A., Swinkels D.W., Perrone L., et al. Effect of body mass index reduction on serum hepcidin levels and iron status in obese children. Int J Obes 2010, 34:1772-1774.
42. Tussing-Humphreys L.M., Nemeth E., Fantuzzi G., Freels S., Holterman A.X., Galvani C., et al. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery. Obesity 2010, 18:2010-2016.
43. Seltzer C.C., Mayer J. Serum iron and iron-binding capacity in adolescents. II. Comparison of obese and nonobese subjects. Am J Clin Nutr 1963, 13:354-361.
44. Menzie C.M., Yanoff L.B., Denkinger B.I., McHugh T., Sebring N.G., Calis K.A., et al. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc 2008, 108:145-148.
45. Failla M.L., Kennedy M.L., Chen M.L. Iron metabolism in genetically obese (ob/ob) mice. J Nutr 1988, 118:46-51.
46. Greenberg A.S., Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006, 83. 461-5S.
47. Weiss G., Goodnough L.T. Anemia of chronic disease. N Engl J Med 2005, 352:1011-1023.
48. Bekri S., Gual P., Anty R., Luciani N., Dahman M., Ramesh B., et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006, 131:788-796.
49. Chow V.T., Phoon M.C. Measurement of serum leptin concentrations in university undergraduates by competitive ELISA reveals correlations with body mass index and sex. Adv Physiol Educ 2003, 27:70-77.
50. Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995, 1:1155-1161.
51. Chung B., Matak P., McKie A.T., Sharp P. Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr 2007, 137:2366-2370.
52. Miraglia del Guidice E., Santoro N., Amato A., Brienza C., Calabrò P., Wiegerinck E.T., et al. Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J Clin Endocrinol Metab 2009, 94:5102-5107.
53. Means R.T. Hepcidin and anaemia. Blood Rev 2004, 18:219-225.
54. Luciani N., Brasse-Lagnel C., Poli M., Anty R., Lesueur C., Cormont M., et al. Hemojuvelin: a new link between obesity and iron homeostasis. Obesity (Silver Spring) 2011, 19:1545-1551.
55. Lin L., Goldberg Y.P., Ganz T. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 2005, 106:2884-2889.
56. Fleming R.E., Sly W.S. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci U S A 2001, 98:8160-8162.
57. Zimmermann M.B., Zeder C., Muthayya S., Winichagoon P., Chaouki N., Aeberli I., et al. Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification. Int J Obes 2008, 32:1098-1104.
58. Cook D.M., Swanson R.C., Eggett D.L., Booth G.M. A retrospective analysis of prevalence of gastrointestinal parasites among school children in the Palajunoj Valley of Guatemala. J Health Popul Nutr 2009, 27:31-40.
59. Duffy T.L., Montenegro-Bethancourt G., Solomons N.W., Belosevic M., Clandinin M.T. Prevalence of giardiasis in children attending semi-urban daycare centres in Guatemala and comparison of 3 Giardia detection tests. J Health Popul Nutr 2013, 31:290-293.
60. Neufeld L.M., Haas J.D., Ruel M.T., Grajeda R., Naeher L.P. Smoky indoor cooking fires are associated with elevated hemoglobin concentration in iron-deficient women. Rev Panam Salud Publica 2004, 15:110-118.
61. Vásquez W.F. Municipal water services in Guatemala: exploring official perceptions. Water Policy 2011, 13:362-374.
62. Rohner F., Woodruff B.A., Aaron G.J., Yakes E.A., Lebana M.A., Rayco-Solon P., et al. Infant and young child feeding practices in urban Philippines and their associations with stunting, anemia, and deficiencies of iron and vitamin A. Food Nutr Bull 2013, 34:S17-S34.
63. Chowdhury S.D., Ghosh T. Undernutrition in Santal children: a biochemical and hematological study. Homo 2013, 64:215-227.